ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Clinical trial NCT03295396 · TERMINATED
Trial details
- NCT number
- NCT03295396
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2022-12-31
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.